检索规则说明:AND代表“并且”;OR代表“或者”;NOT代表“不包含”;(注意必须大写,运算符两边需空一格)
检 索 范 例 :范例一: (K=图书馆学 OR K=情报学) AND A=范并思 范例二:J=计算机应用与软件 AND (U=C++ OR U=Basic) NOT M=Visual
作 者:赵志敏[1,2] 黄恺 沈丽[1,2] 刘成海 叶伟成[1,2] ZHAO Zhimin;HUANG Kai;SHEN Li;LIU Chenghai;YE Weicheng(Institute of Liver Diseases, Shuguang Hospital,Shanghai University of Traditional Chinese Medicine, Shanghai 201203, China;Shanghai Key Laboratory of Traditional Chinese Clinical Medicine,Shanghai 201203,China)
机构地区:[1]上海中医药大学附属曙光医院·肝病研究所,上海201203 [2]上海市中医临床重点实验室,上海201203
出 处:《世界中医药》2020年第19期2850-2856,共7页World Chinese Medicine
基 金:国家自然科学基金项目(81473404,81102702)。
摘 要:目的:探讨欧当归内酯A调节纤维化肝脏NO释放的抗肝纤维化作用机制。方法:40只Wistar大鼠随机分为正常组、模型组、欧当归内酯A 3 mg/kg组、欧当归内酯A 6 mg/kg组,每组10只。以四氯化碳(CCl4)与高脂低蛋白饮食复合因素诱导肝纤维化模型,连续6周。药物观察组于造模第4周腹腔注射给药至结束。观察肝组织炎性反应及胶原沉积、eNOS表达及MDA、SOD、NO、NOS水平。体外以800μmol/L氯化钴作用于SK-HEP-1细胞24 h诱导细胞缺氧损伤,药物处理后观察细胞活力、vWF表达、上清及胞内NO水平。结果:与模型组比较,欧当归内酯A各组肝细胞变性和炎性反应坏死有所减轻,纤维化改善;高剂量组SOD和MDA显著改善,NO和NOS降低,eNOS阳性表达下降(P<0.05)。体外实验显示,药物干预后细胞活力得到改善,vWF平均荧光强度减弱,NO释放显著改善(P<0.05)。结论:欧当归内酯A具有抗肝纤维化的作用,其机制可能与抗脂质过氧化损伤,改善内皮细胞功能,调节NO释放有关。Objective:To explore the effects of levistilide A on anti-hepatic fibrosis mechanism of regulating the release of NO from fibrotic liver.Methods:A total of 40 Wistar rats were randomly divided a control group,a model group,a levistilide A 3 mg/kg group and a levistilide 6 mg/kg group,with 10 rats in each group.The liver fibrosis model was induced by a combination of carbon tetrachloride(CCl4)and a high-fat and low-protein diet for 6 consecutive weeks.The drug treatment group was given intraperitoneal injection to the end on the 4th week of modeling.Liver tissue inflammatory reaction and collagen deposition,eNOS expression and MDA,SOD,NO,NOS levels were observed.In vitro,800μmol/L cobalt chloride was applied to SK-HEP-1 cells for 24 h to induce cell hypoxia.After drug treatment,cell viability,vWF expression,supernatant and intracellular NO levels were observed.Results:Compared with those in the model group,the degeneration and inflammatory necrosis of Levistilide A in each group were reduced,and the fibrosis was improved;the high-dose group SOD and MDA significantly improved,NO and NOS decreased,and the positive expression of eNOS decreased(P<0.05).In vitro experiments showed that cell viability was improved after drug intervention,the average fluorescence intensity of vWF was weakened,and the release of NO was significantly improved(P<0.05).Conclusion:Levistilide A can inhibit liver fibrosis,the mechanism may be related to Levistilide A,anti-lipid peroxidation,and regulate the release of NO.
正在载入数据...
正在载入数据...
正在载入数据...
正在载入数据...
正在载入数据...
正在载入数据...
正在载入数据...
正在链接到云南高校图书馆文献保障联盟下载...
云南高校图书馆联盟文献共享服务平台 版权所有©
您的IP:18.222.182.107